急性卒中诊疗中平板探测器CT协议的 patient 有效剂量测量
研究用拟人体模和热释光剂量计测量平板探测器CT全脑成像、双期血管成像和灌注协议的有效剂量,并与既往报道的多层螺旋CT有效剂量比较。除高剂量双期平板探测器CT血管成像协议外,其余平板探测器CT应用的有效剂量与多层螺旋CT报道值相差不超过1 mSv,但常用卒中方案的眼晶状体剂量超过推荐年剂量两倍。
要点
- 平板探测器CT全脑成像20秒/7秒协议有效剂量分别为2.6 mSv/2.4 mSv,眼晶状体剂量24/23 mGy。
- 双期平板探测器CT血管成像高剂量/低剂量协议有效剂量分别为8.9/2.8 mSv,眼晶状体剂量60/14 mGy。
- 常用卒中方案的眼晶状体有效剂量超过推荐年剂量两倍。
诊断标准与关键数值
- 全脑成像20秒协议有效剂量2.6 mSv、眼晶状体剂量24 mGy;7秒协议有效剂量2.4 mSv、眼晶状体剂量23 mGy。
- 双期平板探测器CT血管成像高剂量协议有效剂量8.9 mSv、眼晶状体剂量60 mGy;低剂量协议有效剂量2.8 mSv、眼晶状体剂量14 mGy。
- 团注跟踪对有效剂量的贡献为0.66 mSv(假设平均持续时间14秒)。
- 多扫描平板探测器CT灌注协议有效剂量5.9 mSv、眼晶状体剂量46 mGy。
临床应用与阅片要点
- 除高剂量双期平板探测器CT血管成像协议外,平板探测器CT应用有效剂量与多层螺旋CT报道值相差不超过1 mSv。
- 常用卒中方案的眼晶状体有效剂量超过推荐年剂量两倍。
- 作者指出未来应评估降低眼晶状体有效剂量的策略,尤其是年轻患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim was to measure the effective dose of flat-detector CT (FDCT) whole-brain imaging, biphasic FDCT angiography (FDCT-A), and FDCT perfusion (FDCT-P) protocols and compare it to previously reported effective dose values of multidetector CT (MDCT) applications.
MATERIALS: We measured effective dose according to the IRCP 103 using an anthropomorphic phantom equipped with thermoluminescent dosimeters (TLDs). Placement was according to anatomical positions of each organ. In total, 60 TLDs (≥ 4 TLDs/organ) were placed into and onto the phantom to account for all relevant organs. Organs within the primary beam were covered with more TLDs. Additionally, we measured dose to the eye lens with two TLDs per eye. Protocols which we routinely use in clinical practice were measured on a biplane angiography system.
RESULTS: The effective dose of the 20-s protocol/7-s protocol for whole-brain imaging was 2.6 mSv/2.4 mSv. The radiation dose to the eye lens was 24/23 mGy. For the biphasic high-/low-dose FDCT-A protocol, the effective dose was 8.9/2.8 mSv respectively. The eye lens dose was 60/14 mGy. The contribution of bolus tracking to the effective dose was 0.66 mSv (assuming average duration of 14 s). The multisweep FDCT-P protocol had an effective dose of 5.9 mSv and an eye lens dose of 46 mGy.
CONCLUSION: Except for the high-dose biphasic FDCT-A protocol, FDCT applications used in neuroradiology have effective doses, which do not deviate more than 1 mSv from previously reported values for MDCT applications. However, the effective dose to the eye lens in commonly used stroke paradigms exceeds the recommended annual dose twofold.
KEY POINTS: • Flat-detector computed tomography (FDCT) can be used for acute and periinterventional imaging of acute stroke patients and in neurointerventions. • Except for the high-dose FDCT angiography protocol, the effective doses do not deviate more than 1 mSv from previously reported values for multidetector CT applications. • Strategies to decrease the effective lens dose especially in younger patients should be evaluated in the future.
引用
- Brehm A, Stamm G, Lüpke M, et al. Effective dose to patient measurements for flat-detector computed tomography protocols in acute stroke care. Eur Radiol. 2020. PMID: 32346793. doi:10.1007/s00330-020-06891-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。